Literature DB >> 20207858

Severe Rift Valley fever may present with a characteristic clinical syndrome.

Summerpal S Kahlon1, Clarence J Peters, James Leduc, Eric M Muchiri, Samuel Muiruri, M Kariuki Njenga, Robert F Breiman, A Clinton White, Charles H King.   

Abstract

Rift Valley fever (RVF) virus is an emerging pathogen that is transmitted in many regions of sub-Saharan Africa, parts of Egypt, and the Arabian peninsula. Outbreaks of RVF, like other diseases caused by hemorrhagic fever viruses, typically present in locations with very limited health resources, where initial diagnosis must be based only on history and physical examination. Although general signs and symptoms of human RVF have been documented, a specific clinical syndrome has not been described. In 2007, a Kenyan outbreak of RVF provided opportunity to assess acutely ill RVF patients and better delineate its presentation and clinical course. Our data reveal an identifiable clinical syndrome suggestive of severe RVF, characterized by fever, large-joint arthralgia, and gastrointestinal complaints and later followed by jaundice, right upper-quadrant pain, and delirium, often coinciding with hemorrhagic manifestations. Further characterization of a distinct RVF clinical syndrome will aid earlier detection of RVF outbreaks and should allow more rapid implementation of control.

Entities:  

Mesh:

Year:  2010        PMID: 20207858      PMCID: PMC2829894          DOI: 10.4269/ajtmh.2010.09-0669

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  31 in total

1.  Outbreak of Rift Valley fever--Yemen, August-October 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-12-01       Impact factor: 17.586

2.  Rift valley fever in South Africa; a study of the 1953 outbreak in the Orange Free State, with special reference to the vectors and possible reservoir hosts.

Authors:  J GEAR; B DE MEILLON; A F LE ROUX; R KOFSKY; R R INNES; J J STEYN; W D OLIFF; K H SCHULZ
Journal:  S Afr Med J       Date:  1955-05-28

3.  Rift Valley fever among domestic animals in the recent West African outbreak.

Authors:  T G Ksiazek; A Jouan; J M Meegan; B Le Guenno; M L Wilson; C J Peters; J P Digoutte; M Guillaud; N O Merzoug; E M Touray
Journal:  Res Virol       Date:  1989 Jan-Feb

4.  Rift Valley fever outbreak--Kenya, November 2006-January 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-02-02       Impact factor: 17.586

5.  Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients.

Authors:  Gianandrea Borgherini; Patrice Poubeau; Frederik Staikowsky; Manuella Lory; Nathalie Le Moullec; Jean Philippe Becquart; Catherine Wengling; Alain Michault; Fabrice Paganin
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079

6.  An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98.

Authors:  Christopher W Woods; Adam M Karpati; Thomas Grein; Noel McCarthy; Peter Gaturuku; Eric Muchiri; Lee Dunster; Alden Henderson; Ali S Khan; Robert Swanepoel; Isabelle Bonmarin; Louise Martin; Philip Mann; Bonnie L Smoak; Michael Ryan; Thomas G Ksiazek; Ray R Arthur; Andre Ndikuyeze; Naphtali N Agata; Clarence J Peters
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

7.  Drought-associated chikungunya emergence along coastal East Africa.

Authors:  Jean-Paul Chretien; Assaf Anyamba; Sheryl A Bedno; Robert F Breiman; Rosemary Sang; Kibet Sergon; Ann M Powers; Clayton O Onyango; Jennifer Small; Compton J Tucker; Kenneth J Linthicum
Journal:  Am J Trop Med Hyg       Date:  2007-03       Impact factor: 2.345

8.  Chikungunya fever in travelers: clinical presentation and course.

Authors:  Winfried Taubitz; Jakob P Cramer; Anette Kapaun; Martin Pfeffer; Christian Drosten; Gerhard Dobler; Gerd D Burchard; Thomas Löscher
Journal:  Clin Infect Dis       Date:  2007-05-23       Impact factor: 9.079

9.  Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005.

Authors:  Kibet Sergon; Ali Ahmed Yahaya; Jennifer Brown; Said A Bedja; Mohammed Mlindasse; Naphtali Agata; Yokouide Allaranger; Mamadou D Ball; Ann M Powers; Victor Ofula; Clayton Onyango; Limbaso S Konongoi; Rosemary Sang; M Kariuki Njenga; Robert F Breiman
Journal:  Am J Trop Med Hyg       Date:  2007-06       Impact factor: 2.345

10.  RIFT VALLEY FEVER : A REPORT OF THREE CASES OF LABORATORY INFECTION AND THE EXPERIMENTAL TRANSMISSION OF THE DISEASE TO FERRETS.

Authors:  T Francis; T P Magill
Journal:  J Exp Med       Date:  1935-08-31       Impact factor: 14.307

View more
  33 in total

1.  Rift Valley Fever Seroprevalence in Coastal Kenya.

Authors:  Elysse N Grossi-Soyster; Tamara Banda; Crystal Y Teng; Eric M Muchiri; Peter L Mungai; Francis M Mutuku; Ginny Gildengorin; Uriel Kitron; Charles H King; A Desiree Labeaud
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

Review 2.  Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.

Authors:  Colm Atkins; Alexander N Freiberg
Journal:  Future Virol       Date:  2017-10-23       Impact factor: 1.831

3.  Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis.

Authors:  Todd M Bell; Virginia Espina; Svetlana Senina; Caitlin Woodson; Ashwini Brahms; Brian Carey; Shih-Chao Lin; Lindsay Lundberg; Chelsea Pinkham; Alan Baer; Claudius Mueller; Elizabeth A Chlipala; Faye Sharman; Cynthia de la Fuente; Lance Liotta; Kylene Kehn-Hall
Journal:  Antiviral Res       Date:  2017-04-23       Impact factor: 5.970

4.  Ultrastructural pathology of human liver in Rift Valley fever.

Authors:  Mubarak Al Shraim; Refaat Eid; Khaled Radad; Noora Saeed
Journal:  BMJ Case Rep       Date:  2016-08-02

Review 5.  Advances in Rift Valley fever research: insights for disease prevention.

Authors:  A Desiree LaBeaud; James W Kazura; Charles H King
Journal:  Curr Opin Infect Dis       Date:  2010-10       Impact factor: 4.915

6.  Cross-sectional survey of Rift Valley fever virus exposure in Bodhei village located in a transitional coastal forest habitat in Lamu county, Kenya.

Authors:  Samuel Muiruri; Ephantus W Kabiru; Eric M Muchiri; Hassan Hussein; Frederick Kagondu; A Desirée LaBeaud; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2014-12-22       Impact factor: 2.345

7.  Planning for Rift Valley fever virus: use of geographical information systems to estimate the human health threat of white-tailed deer (Odocoileus virginianus)-related transmission.

Authors:  Sravan Kakani; A Desirée LaBeaud; Charles H King
Journal:  Geospat Health       Date:  2010-11       Impact factor: 1.212

8.  Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.

Authors:  Brian H Bird; Louis H Maartens; Shelley Campbell; Baltus J Erasmus; Bobbie R Erickson; Kimberly A Dodd; Christina F Spiropoulou; Deborah Cannon; Clifton P Drew; Barbara Knust; Anita K McElroy; Marina L Khristova; César G Albariño; Stuart T Nichol
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

Review 9.  Monitoring Symptoms of Infectious Diseases: Perspectives for Printed Wearable Sensors.

Authors:  Ala'aldeen Al-Halhouli; Ahmed Albagdady; Ja'far Alawadi; Mahmoud Abu Abeeleh
Journal:  Micromachines (Basel)       Date:  2021-05-27       Impact factor: 2.891

10.  Measuring the burden of arboviral diseases: the spectrum of morbidity and mortality from four prevalent infections.

Authors:  A Desirée Labeaud; Fatima Bashir; Charles H King
Journal:  Popul Health Metr       Date:  2011-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.